胎儿生长受限患者母体血清TSH变化的临床研究

Clininic Study on Maternal Serum TSH with Fetal Growth Restriction

目的：探讨胎儿生长受限（FGR）患者母体血清中促甲状腺激素的变化规律。方法：对拟诊的34例FGR患者进行实时监测其母体血清促甲状腺素（TSH）水平。并与18例同期正常妊娠者比较。结果：从妊娠32～37周,确诊FGR患者母体TSH水平均较对照组高（P〈0.01）;拟诊FGR患者母体TSH水平也较对照组高（P〈0.05）。结论：母体甲状腺功能不良与确诊和拟诊FGR的发病有关。

Objective：To study the maternal serum thyroid-stimulating-hormone（TSH） with fetal growth restriction （FGR）. Methods：The serum TSH was detected in 34 gravida with FGR and 18 nomal gravida. Results：From 32 to 37 weeks of pregnancy,the concentration of TSH in gravida with confirmed diagnostic FGR was higher than that in contral group （P〈0.01）,and the concentration of TSH in gravida with preliminary diagnostic FGR was higher than that in contral group（P〈0.05）. Conclusions：The confirmed diagnostic and preliminary diagnostic FGR are connected with maternal dysthyroidism.